Jason Kolbert

Dec 22, 2025

Jason Kolbert rated NRSN as Buy on Dec 22, 2025, setting a price target of 14. Shares have remained stable near 0.81, leaving the 14 target still in play.

Dec 22, 2025

On Dec 22, 2025, HUMA was given a Buy rating by Jason Kolbert, with a target price of 25. The stock traded sideways with a % move, keeping the bullish thesis unresolved.

Dec 19, 2025

AVXL received a Buy rating from Jason Kolbert on Dec 19, 2025, aiming for 24. Price action was muted, as shares hovered around 3.67 despite the bullish outlook.

Dec 18, 2025

On Dec 18, 2025, Jason Kolbert published a Buy outlook on MNOV, with a target of 9. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 1.43.

Dec 18, 2025

Jason Kolbert on Dec 18, 2025 assigned CRMD a Buy rating, with a price target of 14. The recommendation remains pending validation as shares consolidate around 12.02.

Dec 18, 2025

On Dec 18, 2025, Jason Kolbert reaffirmed VNRX with a Buy rating, targeting 5. Market indecision has kept the 5 target in a holding pattern.

Dec 17, 2025

CANF was rated Buy by Jason Kolbert on Dec 17, 2025, with a price objective of 11. This case shows how bullish projections can fail, with the stock now below 0.2521.

Dec 16, 2025

On Dec 16, 2025, Jason Kolbert initiated coverage on MVIS with a Buy rating and target of 3. Neutral price movement of 2.75% leaves room for interpretation.

Dec 16, 2025

Jason Kolbert issued a Buy recommendation for IBRX on Dec 16, 2025, price target set at 24. The target of 24 remains in play, though confirmation will depend on future moves.

Dec 16, 2025

On Dec 16, 2025, CTSO was evaluated by Jason Kolbert, who gave a Buy rating and target of 10. So far, the Buy call awaits clearer momentum, with shares flat at 0.6368.

Dec 15, 2025

Jason Kolbert rated MDCX as Buy on Dec 15, 2025, setting a price target of 27. The stock has underperformed, dropping 7.65% despite the bullish target of 27.

Dec 15, 2025

On Dec 15, 2025, QNCX was given a Buy rating by Jason Kolbert, with a target price of 5. Despite the Buy call, shares fell from 3.57 to 3.57, challenging the optimistic stance.

Dec 15, 2025

OSTX received a Buy rating from Jason Kolbert on Dec 15, 2025, aiming for 20. The rating hasn’t played out as hoped, with the stock trading 7.78% below expectations.

Dec 12, 2025

On Dec 12, 2025, Jason Kolbert published a Buy outlook on ANIX, with a target of 10. Market action contradicted the Buy thesis, as shares slipped to 3.3.

Dec 11, 2025

Jason Kolbert on Dec 11, 2025 assigned PSTV a Buy rating, with a price target of 5. The call has struggled to gain traction, with shares losing 21.04%.

Dec 10, 2025

On Dec 10, 2025, Jason Kolbert reaffirmed CLNN with a Buy rating, targeting 23. Market indecision has kept the 23 target in a holding pattern.

Dec 09, 2025

VERI was rated Buy by Jason Kolbert on Dec 09, 2025, with a price objective of 23. This case shows how bullish projections can fail, with the stock now below 5.01.

Dec 09, 2025

On Dec 09, 2025, Jason Kolbert initiated coverage on COYA with a Buy rating and target of 15. The Buy call has yet to be validated as shares remain 9.51 away from the target.

Dec 05, 2025

Jason Kolbert issued a Buy recommendation for CRVO on Dec 05, 2025, price target set at 31. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Dec 04, 2025

On Dec 04, 2025, PAPL was evaluated by Jason Kolbert, who gave a Buy rating and target of 5. Investors saw limited payoff as shares fell short of the 5 target.

Dec 04, 2025

Jason Kolbert rated HOVR as Buy on Dec 04, 2025, setting a price target of 11. The stock has underperformed, dropping 5.59% despite the bullish target of 11.

Dec 04, 2025

On Dec 04, 2025, HOTH was given a Buy rating by Jason Kolbert, with a target price of 5. Despite the Buy call, shares fell from 1.09 to 1.09, challenging the optimistic stance.

Dec 04, 2025

CTXR received a Buy rating from Jason Kolbert on Dec 04, 2025, aiming for 6. The rating hasn’t played out as hoped, with the stock trading 14.40% below expectations.

Dec 03, 2025

On Dec 03, 2025, Jason Kolbert published a Buy outlook on NRXP, with a target of 34. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 2.37.

Dec 03, 2025

Jason Kolbert on Dec 03, 2025 assigned EVTL a Buy rating, with a price target of 14. The recommendation remains pending validation as shares consolidate around 5.56.

Dec 01, 2025

On Dec 01, 2025, Jason Kolbert reaffirmed AREC with a Buy rating, targeting 6. Shares slid 19.72% despite the recommendation, highlighting downside risks.

Dec 01, 2025

OMER was rated Buy by Jason Kolbert on Dec 01, 2025, with a price objective of 36. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

Nov 28, 2025

On Nov 28, 2025, Jason Kolbert initiated coverage on CLGN with a Buy rating and target of 12. The Buy call has yet to be validated as shares remain 10.48 away from the target.

Nov 25, 2025

On Nov 25, 2025, LCTX was evaluated by Jason Kolbert, who gave a Buy rating and target of 2. So far, the Buy call awaits clearer momentum, with shares flat at 1.68.

Nov 24, 2025

Jason Kolbert rated ADUR as Buy on Nov 24, 2025, setting a price target of 46. The stock has underperformed, dropping 7.39% despite the bullish target of 46.

Nov 20, 2025

FBLG received a Buy rating from Jason Kolbert on Nov 20, 2025, aiming for 15. The rating hasn’t played out as hoped, with the stock trading 20.36% below expectations.

Nov 20, 2025

On Nov 20, 2025, Jason Kolbert published a Buy outlook on NNOX, with a target of 8. Market action contradicted the Buy thesis, as shares slipped to 2.99.

Nov 20, 2025

Jason Kolbert on Nov 20, 2025 assigned TVGN a Buy rating, with a price target of 5. The call has struggled to gain traction, with shares losing 8.13%.

Nov 19, 2025

On Nov 19, 2025, Jason Kolbert reaffirmed KAPA with a Buy rating, targeting 9. The recommendation was supported by strong follow-through as the stock rose from 0.8584 to 0.8584.

Nov 19, 2025

RVPH was rated Buy by Jason Kolbert on Nov 19, 2025, with a price objective of 2. A bullish response from the market helped close the gap of 1.40 to the target.

Nov 19, 2025

On Nov 19, 2025, Jason Kolbert initiated coverage on GOVX with a Buy rating and target of 6. The Buy call has yet to be validated as shares remain 5.84 away from the target.

Nov 14, 2025

On Nov 14, 2025, TRVI was evaluated by Jason Kolbert, who gave a Buy rating and target of 19. This case illustrates how a timely bullish rating can translate into tangible gains of 14.42%.

Nov 13, 2025

Jason Kolbert rated IMUX as Buy on Nov 13, 2025, setting a price target of 8. The stock has underperformed, dropping 19.58% despite the bullish target of 8.

Nov 13, 2025

On Nov 13, 2025, LUNG was given a Buy rating by Jason Kolbert, with a target price of 14. The stock rallied 63.52% after the rating, narrowing the gap to the target of 14 and validating the bullish stance.

Nov 11, 2025

XAIR received a Buy rating from Jason Kolbert on Nov 11, 2025, aiming for 11. The rating hasn’t played out as hoped, with the stock trading 37.55% below expectations.

Nov 07, 2025

On Nov 07, 2025, Jason Kolbert published a Buy outlook on RCEL, with a target of 14. Market action contradicted the Buy thesis, as shares slipped to 3.46.

Nov 06, 2025

Jason Kolbert on Nov 06, 2025 assigned CNTX a Buy rating, with a price target of 9. The Buy call aligned well with market performance, producing a gain of 18.69%.

Nov 05, 2025

On Nov 05, 2025, Jason Kolbert reaffirmed CMPX with a Buy rating, targeting 30. The recommendation was supported by strong follow-through as the stock rose from 4.99 to 4.99.

Nov 05, 2025

BMEA was rated Buy by Jason Kolbert on Nov 05, 2025, with a price objective of 12. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

Nov 03, 2025

On Nov 03, 2025, Jason Kolbert initiated coverage on ESLA with a Buy rating and target of 16. The Buy call has yet to be validated as shares remain 14.31 away from the target.

Oct 28, 2025

Jason Kolbert issued a Buy recommendation for CODX on Oct 28, 2025, price target set at 3. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Oct 27, 2025

On Oct 27, 2025, URGN was evaluated by Jason Kolbert, who gave a Buy rating and target of 25. This case illustrates how a timely bullish rating can translate into tangible gains of 9.35%.

Oct 17, 2025

Jason Kolbert rated MSAI as Buy on Oct 17, 2025, setting a price target of 3. The stock has underperformed, dropping 13.07% despite the bullish target of 3.

Aug 08, 2025

CARM received a Buy rating from Jason Kolbert on Aug 08, 2025, aiming for 1. The rating hasn’t played out as hoped, with the stock trading 83.48% below expectations.

Apr 02, 2025

On Apr 02, 2025, Jason Kolbert published a Buy outlook on SCLX, with a target of 18. Shares gained 37.81%, underscoring the accuracy of the bullish outlook toward 18.

Mar 31, 2025

Jason Kolbert on Mar 31, 2025 assigned CKPT a Buy rating, with a price target of 4.8. The Buy call aligned well with market performance, producing a gain of 5.45%.

Mar 24, 2025

On Mar 24, 2025, Jason Kolbert reaffirmed IMNN with a Buy rating, targeting 29. Shares slid 76.64% despite the recommendation, highlighting downside risks.

Nov 13, 2024

On Nov 13, 2024, Jason Kolbert initiated coverage on MRNS with a Buy rating and target of 3. The stock’s climb of 81.94% since the call highlights the foresight in the rating.

Sep 24, 2024

Jason Kolbert issued a Buy recommendation for LUMO on Sep 24, 2024, price target set at 16. Investors following the Buy call captured upside momentum, with shares now at 4.34.